ALZN - alzamend.com Operating profit EBITDA
Alzamend Neuro, Inc. (ALZN) is implementing LiPRO technology for the safe treatment of Alzheimer's, while the GURU.Markets service features a linear chart of absolute operating profit, where the 0.00 metric indicates the status of the cash flow. Patent protection ensures long-term value growth, and strict adherence to the cold chain during drug transportation guarantees their efficacy throughout clinical trials.
Alzamend Neuro (ALZN) - metric breakdowns and financial figures
- share price and consensus valuation forecast:
- market capitalization statistics:
- book value of equity indicators:
- debt level and financial liquidity data:
Debt to Equity Ratio Alzamend Neuro, Inc.|ALZN - Long-Term Debt to Capital|Short-Term Debt to Capital Ratio Alzamend Neuro Inc.|ALZN - Company Total Debt|Debt to Net Assets Ratio Alzamend Neuro|ALZN - Company Long-Term Debt|Company Short-Term Indebtedness Alzamend Neuro|Immediate Liquidity alzamend.com
- earnings and multiples data:
ALZN - Net Income|Projected Future Earnings Alzamend Neuro, Inc.|ALZN - Price to Earnings Ratio|Future Price to Earnings Multiple Alzamend Neuro Inc.|ALZN - Price/Earnings to Growth Ratio|Company Value to EBITDA Alzamend Neuro|ALZN - Operating profit before deduction of amortization|Earnings per share for the trailing year Alzamend Neuro|ALZN - Net earnings per share (EPS TTM)|Year-over-year net earnings per share change for the last twelve months alzamend.com|ALZN - Earnings per share growth in current year|Projected earnings per share growth rate for next year Alzamend Neuro, Inc.
Fundamental company valuation:Alzamend Neuro, Inc.
This indicator measures the volume of cash flow from core operations before taxes, demonstrating the business's ability to generate liquidity excluding depreciation and amortization. An analysis based on the EBITDA_Co valuation allows for the tracking of capital inflows, which is critically important for Alzamend Neuro, Inc. (ALZN) when financing clinical trials for lithium-based drugs and maintaining competitiveness against anti-amyloid antibodies.
Competitors of Alzamend Neuro, Inc. (ALZN)
BIIB (Biogen Idec) - Profit before deduction of interest, taxes, depreciation and amortization|Neurocrine Biosciences - Operating profit EBITDA|RGC - Operating profit EBITDA|Axsome Therapeutics, Inc. (AXSM) - Profit before payment of interest, taxes and amortization|Operating profit before deduction of amortization ACADIA Pharma|XENE (Xenon Pharmaceuticals Inc) - Operating profit EBITDA|Profit before interest, taxes and amortization Viking Therapeutics Corp VKTX|Profit before payment of interest, taxes and amortization Supernus Pharmaceuticals (SUPN)|catalystpharma.com - Operating profit before amortization|Operating profit EBITDA DNLI (Denali Therapeutics Inc.)|HRMY: Operating profit before amortization|BHVN: Operating profit before deduction of amortization|Income before deduction of interest, taxes and amortization AMLX (Amylyx Corp)|Trevi Therapeutics (TRVI) - Profit before payment of interest, taxes and amortization|Operating profit before amortization PRAX|AVXL (Anavex Life Sciences Corp.) - Operating profit EBITDA|Profit before interest, taxes and amortization CeriBell Inc CBLL|Operating profit before deduction of amortization PRTA (Prothena Corp)|Operating profit EBITDA alector.com (ALEC)|Profit before payment of interest, taxes and amortization Annexon, Inc. ANNX|Income before deduction of interest, taxes and amortization OMER|NGNE - Profit before payment of interest, taxes and amortization|Profit before interest, taxes and amortization AC Immune S.A.|VYGR (Voyager Pharma) - Operating profit before deduction of amortization|Neumora Corp - Income before deduction of interest, taxes and amortization|SCLX (Scilex Holding Company) - Operating profit EBITDA|tevogen.com (TVGN) - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization Alpha Cognition (ACOG)|Cognition Therapeutics Inc. - Operating profit before amortization|Operating profit EBITDA IKT (Inhibikase)|SAVA - Operating profit before deduction of amortization|ASRT: Operating profit before deduction of amortization|Operating income before deduction of amortization Coya Therapeutics, Inc. COYA|VTGN: Operating profit EBITDA|Ovid Therapeutics (OVID) - Operating profit EBITDA|Profit before payment of interest, taxes and amortization Acumen Pharma|Profit before payment of interest, taxes and amortization CRVO|Operating profit before deduction of amortization ATHE (Alterity Therapeutics)|CLNN: Profit before deduction of interest, taxes, depreciation and amortization|Profit before payment of interest, taxes and amortization PepGen PEPG|JUNS: Operating profit before amortization|RLMD - Profit before payment of interest, taxes and amortization|ANVS (Annovis Bio Corporation) - Operating profit before amortization|GRCE: Operating profit EBITDA|Profit before interest, taxes and amortization fireflyneuro.com (AIFF)|Operating profit before deduction of amortization KLTO|Operating profit EBITDA NeuroSense Therapeutics, Ltd.|Profit before payment of interest, taxes and amortization Reviva Pharmaceuticals Holdings (RVPH)|MTVA (metaviatx.com) - Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization NeurAxis, Inc. NRXS|Helius Medical Technologies, Inc. (HSDT) - Profit before interest, taxes and amortization|Passage Bio Corp - Operating profit EBITDA|NEUP - Operating profit EBITDA|Minerva Neurosciences Corp (NERV) - Profit before payment of interest, taxes and amortization|ATHA (Athira Pharma Corp) - Profit before payment of interest, taxes and amortization|Operating profit before deduction of amortization ADXN|Cyclerion - Profit before deduction of interest, taxes, depreciation and amortization|Operating profit EBITDA PTIX|Operating profit EBITDA pasitheaclinics.com (KTTA)|Profit before payment of interest, taxes and amortization Cortigent CRGT|ATXI - Operating profit before deduction of amortization|Brainstorm Cell - Operating profit EBITDA|Profit before interest, taxes and amortization caratherapeutics.com|Chromocell Therapeutics Corp. (CHRO) - Profit before payment of interest, taxes and amortization|Operating profit before amortization ELYM|ITCI (Intra-Cellular Therapies Inc.) - Operating profit EBITDA|Operating profit before amortization LBPH (Longboard)|Operating profit before deduction of amortization MRNS (Marinus Pharmaceuticals)|NKGN (nkgenbiotech.com) - Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization NeuroBo Pharmaceuticals, Inc. NRBO|SAGE: Operating profit before amortization|Neurotrope - Operating profit EBITDA|Profit before interest, taxes and amortization Trevena Inc|VIGL (vigilneuro.com) - Operating profit before deduction of amortization|anewmeds.com (WENA) - Operating profit EBITDA|Profit before payment of interest, taxes and amortization Cerevel Therapeutics, Inc.
